The use of novel tumour markers and statistical models in the preoperative diagnosis of ovarian cancer

Malignant ovarian tumours are diagnosed at an advanced stage in 75% of cases and they have the highest mortality figures of all gynaecological cancers. As the treatment of benign and malignant adnexal masses is significantly different it is important to be able to reliably distinguish between them preoperatively. Thus, women with malignancies could be referred to cancer centres, whilst those with benign conditions could be offered more conservative management.

Grantor dc:publisher

The University of Edinburgh

Year dc:date.issued

2008

Author dc:creator

• Lawrence, Alexandra Claire

Handle dc:identifier.uri

http://hdl.handle.net/1842/29843

OAI identifier oai:identifier

oai:era.ed.ac.uk:1842/29843